Global Leader in Genetically Engineered Models Taconic Biosciences is a globally recognized leader in providing genetically engineered rodent models and services, offering a wide range of animal solutions for research purposes worldwide. This market leadership positions Taconic as a key partner for institutions and companies seeking high-quality research models.

Innovative Product Portfolio Launches Taconic's continuous innovation is evident from recent launches like the FcResolv NOG, ExpressMODEL CRISPR platform, and huNOG-EXL EA humanized immune system mouse. These cutting-edge products address specific research needs, presenting opportunities for sales teams to promote these solutions to relevant research facilities and pharmaceutical companies.

Expansion into New Markets The recent expansion of facilities to Indiana signifies Taconic's commitment to broadening its reach and enhancing service capabilities in different regions. This expansion opens doors for sales professionals to explore partnerships and collaborations with research facilities in Indiana and adjacent markets, creating new revenue streams.

Key Partnerships and Collaborations Taconic's partnerships with Nuveen Real Estate and Cure Rare Disease demonstrate the company's collaborative approach towards advancing research and development in the life sciences sector. Leveraging these alliances, sales teams can explore joint initiatives and co-marketing opportunities to drive sales growth.

Financially Stable Revenue Stream With a revenue ranging between $100M and $1B, Taconic Biosciences showcases financial stability and growth potential. This financial health provides a secure foundation for sales professionals to confidently engage with potential clients and investors, highlighting the company's reliability and sustainability in the biotechnology research market.